In a head-to head trial comparing A...
In a head-to head trial comparing Alimta (pemetrex Eli Lilly and Company, Indianapolis, IN) with Taxotere (docetaxel, Aventis Pharmaceuticals, Inc., Bridgewater, NJ) Alimta showed a similiar survival benefit with significantly fewer side results in subjects with returning non-small cell lung cancer. flows of this Phase 3 global meditation enrolled 571 subjects previously treated with chemotherapy. Of these subdues 283 were randomized to receive docetaxel
Free Song Lyric , Lip Plumper And Lip Gloss , Halloween Costumes , Sarafem Description |